RBA Wealth Management’s AbbVie ABBV Stock Holding History

RBA Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,053	Closed	-$487K	–	91
2023 Q1	$487K	Sell	3,053 -18,808	-86%	-$2.88M	0.24%	60
2022 Q4	$3.53M	Buy	21,861 +394	+2%	+$60.4K	1.85%	28
2022 Q3	$2.88M	Buy	21,467 +745	+4%	+$107K	1.66%	32
2022 Q2	$3.17M	Buy	20,722 +406	+2%	+$62K	1.76%	31
2022 Q1	$3.29M	Buy	20,316 +1,052	+5%	+$153K	1.58%	34
2021 Q4	$2.61M	Buy	19,264 +2,802	+17%	+$331K	1.23%	38
2021 Q3	$1.78M	Buy	16,462 +1,441	+10%	+$165K	4.28%	10
2021 Q2	$1.69M	Buy	15,021 +899	+6%	+$101K	3.59%	12
2021 Q1	$1.53M	Buy	14,122 +1,031	+8%	+$110K	1.3%	33
2020 Q4	$1.4M	Buy	13,091 +4,516	+53%	+$434K	0.85%	51
2020 Q3	$751K	Buy	8,575 +3,487	+69%	+$328K	0.51%	63
2020 Q2	$500K	Buy	+5,088	New	+$448K	0.36%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBA Wealth Management's ABBV Position: Q2 2023 in Review

RBA Wealth Management sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 3,053 shares — an estimated $487K sold.

RBA Wealth Management first reported a position in ABBV in Q2 2020 and held it in 12 quarters. The position peaked at $3.53M in Q4 2022. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

RBA Wealth Management reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
RBA Wealth Management sold 3,053 AbbVie shares in Q2 2023, an estimated $487K.
RBA Wealth Management first reported a position in AbbVie in Q2 2020 and held it in 12 quarters.
RBA Wealth Management's AbbVie position peaked at $3.53M in Q4 2022.
3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on RBA Wealth Management's 13F filing for Q2 2023, filed 21 Jul 2023.